• SENSEX 82,618.65
    563.54 (+0.69%)
  • BANKNIFTY 56,461.90
    402.55 (+0.72%)
  • Garden Reach Sh.
    3,034.00 1,180.10(%)
  • Enviro Infra
    251.85 392.00(%)
  • Waaree Energies
    2,947.00 1,808.65(%)
  • Multi Comm. Exc.
    8,808.85 8,357.25(%)
  • Welspun Living
    142.00 213.10(%)
  • Vodafone Idea
    7.19 19.15(%)
  • M T N L
    57.90 101.88(%)
  • Bharat Electron
    409.30 240.15(%)
  • Cochin Shipyard
    2,120.50 1,180.45(%)
  • Sammaan Capital
    146.45 179.35(%)
  • Netwrk.18 Media
    61.82 106.01(%)
  • Mazagon Dock
    3,216.00 1,917.95(%)
  • Hind.Aeronautics
    4,794.30 3,045.95(%)
  • Hyundai Motor I
    2,145.00 2,083.60(%)
  • Dixon Technolog.
    14,087.00 10,613.00(%)
  • Vishal Mega Mart
    137.80 134.50(%)
  • Tata Motors
    678.80 1,179.05(%)
  • BEML Ltd
    4,422.00 2,346.35(%)
  • Data Pattern
    2,805.00 1,350.50(%)
  • Suzlon Energy
    63.93 46.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Cian Healthcare Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 74131.0
  • ISIN : INE05BN01019
4.14 0 (0.24%)
  • As on 25 Jun 2025 (EOD)

  • Today’s Low

    4.06

  • Today’s High

    4.15

  • Open

    4.15

  • Perv Close

    4.13

  • 52W Low

    2.97

  • 52W High

    26.20

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    10.35

  • Div & Yield %

    0.00

  • Book Value(₹)

    16.87

  • Debt-Equity Ratio

    0.24

  • AGM Date

    24-Jun-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    1.01

  • Mar.Cap (₹Cr.)

    10.35

  • RONW (%)

    0.39

  • ROCE (%)

    4.66

Score Board

  • Equity (₹ in Cr.)

    25.00

  • BV (₹)

    16.90

  • Sales( ₹ in Cr.)

    30.88

  • NP (in Cr.)

    -7.42

  • NP Var(%)

    -2013.0

  • Div%

    0.0

  • CPS (₹)

    -1.90

  • EPS (₹)

    -3.00

  • Traded Value (₹ in Lakhs)

    10.35

  • 52 Week High

    26.20

  • 52 Week Low

    2.97

  • Price BSE

    4.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    10.35

  • P/C Ratio

    -2.10

  • P/E Ratio

    -1.30

  • Price Vs.BV

    -3.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 58.75 67.56 64.10 72.38 57.05 62.44
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 58.75 67.56 64.10 72.38 57.05 62.44
Other Income 1.07 0.58 0.48 0.21 0.80 0.99
Stock Adjustments 10.65 4.85 6.96 1.28 0.43 0.00
Total Income 70.47 72.99 71.54 73.87 58.28 63.43
EXPENDITURE :            
Raw Materials 44.68 45.80 45.20 37.32 27.37 40.42
Power and Fuel Cost 0.07 0.07 0.06 0.05 0.09 0.15
Employee Cost 7.18 7.76 7.72 6.44 3.96 4.78
Other Manufacturing Expenses 4.73 4.51 5.96 13.65 12.48 5.05
Selling and Administration Expenses 4.21 3.57 4.32 4.24 4.24 3.52
Miscellaneous Expenses 0.97 1.64 2.84 2.65 1.71 0.67
Employee Benefit Expenses 7.18 7.76 7.72 6.44 3.96 4.78
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 61.84 63.35 66.10 64.35 49.85 54.58
Operating Profit 8.62 9.63 5.44 9.52 8.43 8.85
Interest 4.93 4.79 5.25 6.40 5.90 5.52
Gross Profit 3.69 4.84 0.19 3.12 2.53 3.33
Depreciation 3.68 3.64 2.57 2.45 2.45 2.39
Profit Before Tax 0.01 1.20 -2.38 0.67 0.08 0.94
Current Tax -0.19 0.20 0.00 0.41 0.15 0.17
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.19 -0.08 -0.10 -0.07 0.00 0.12
Reported Net Profit 0.39 1.08 -2.28 0.33 -0.07 0.66
Extraordinary Items 0.00 0.03 -0.07 -0.08 0.07 -0.02
Adjusted Net Profit 0.39 1.05 -2.21 0.41 -0.14 0.68
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 -12.00
P & L Balance brought forward 0.62 -0.46 1.81 1.49 1.56 12.91
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 1.00 0.62 -0.46 1.81 1.49 1.56
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.16 0.43 -0.91 0.14 -0.03 0.38
Earnings Per Share(Adj)-Unit Curr 0.16 0.43 -0.91 0.14 -0.03 -
Book Value 24.73 24.57 24.14 25.62 25.48 12.64
Book Value(Adj)-Unit Curr 24.73 24.57 24.14 25.62 25.48 -

Shareholding Pattern

  • Promoter Group

    27.10%

  • Public Share Holding

    72.90%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 3,951,050 15.81 3,951,050 3
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,823,847 11.30 2,823,847 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 6,774,897 27.10 6,774,897 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 1,140,000 4.56 1,140,000 22
Clearing Members 14,000 0.06 14,000 3
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 416,000 1.66 416,000 20
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 764,208 3.06 764,208 64
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 10,536,153 42.15 10,536,153 128
Individuals holding nominal share capital up to Rs. 1 lakh 5,350,506 21.41 5,350,506 1,259
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 18,220,867 72.90 18,220,867 1,496
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 24,995,764 100.00 24,995,764 1,501

Company Background

Cian Healthcare LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Cian Healthcare Ltd
  • BSE Code : 74131.0
  • ISIN : INE05BN01019

  • Incorporation Year

    2003

  • Registered Office

    Milkat No 3339 BNo 1 Phursungi
    From Southside CS NO 227/2, Pune,
    Maharashtra-412308

  • Telephone

    91-020-26982792

  • FAX

  • Chairman

  • Managing Director

    Suraj Zanwar

  • Company Secretary

  • Auditor

    Agarwal Mahesh K & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No 56-2 ,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Cian Healthcare Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Cian Healthcare 4.14 59.81 58.75 -0.53 4.43
Abbott India 31,510.65 6,097.18 5,848.91 47.34 44.71
Astrazeneca Phar 8,798.50 1,330.33 1,295.53 190.03 33.26
P & G Health Ltd 5,912.35 1,166.89 1,151.26 39.07 39.76
Glaxosmi. Pharma 3,227.35 3,866.05 3,723.49 59.49 58.72
Cipla 1,502.85 20,029.57 19,044.85 23.53 21.40
Amrutanjan Healt 720.20 437.58 421.23 40.97 20.84
Guj. Themis Bio. 331.75 174.19 169.82 74.05 44.82
Fermenta Biotec. 305.00 315.24 307.09 13.28 4.10
Bliss GVS Pharma 148.60 638.96 605.46 22.69 11.19
Ambalal Sarabhai 35.73 11.70 3.81 33.08 1.92